Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Management of the antiphospholipid syndrome: new approaches
International Journal of Clinical Rheumatology, 10/19/09
Seif AM et al. – The antiphospholipid syndrome (APS) is an autoimmune, multisystemic disorder associated with recurrent thrombosis (arterial and/or venous) and pregnancy loss, among other clinical manifestations. These new treatments – potentially more effective and with fewer side effects – might be used in the future to treat clinical manifestations of this disease that are associated with devastating consequences, and are pending adequate clinical trials.
Related Articles
Common infectious agents prevalence in antiphospholipid syndrome
Lupus, 11/05/09
Relevance Score: 70%
The Cardiac Manifestations of Antiphospholipid Syndrome and Their Echocardiographic Recognition
Journal of The American Society of Echocardiography, 10/09/09
Relevance Score: 69%
Catastrophic antiphospholipid syndrome in a patient with Down syndrome
Lupus, 10/05/09
Relevance Score: 68%
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study
The Lancet Neurology, 10/16/09
Relevance Score: 66%
Right atrium myxoma coexisting with antiphospholipid syndrome
Cardiovascular Ultrasound, 10/12/09
Relevance Score: 66%
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Genetic background of systemic sclerosis: autoimmune genes take centre stage
Rheumatology, 11/23/09
Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity
Rheumatology, 11/20/09
T Cell Responses to Steroid Cytochrome P450 21-Hydroxylase in Patients with Autoimmune Primary Adrenal Insufficiency
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study
Osteoporosis International, 11/25/09
Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
Osteoporosis International, 11/25/09
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


